Juul Labs reaches $438.5 million settlement in youth marketing probe

Juul Labs has reached a tentative agreement to pay $438.5 million to a number of states investigating the company's sales and marketing practices, including its efforts to appeal to children and its contribution to the teenage vaping crisis, multiple outlets reported Tuesday.
The probe, led by more than 30 states and territories, "found that the company appealed to young people by hiring young models, using social media to court teenagers, and giving out free samples," writes The New York Times.
"We think that this will go a long way in stemming the flow of youth vaping," said Connecticut Attorney General William Tong, who led negotiations for multiple parties in the probe, per The Washington Post. "We are under no illusions and cannot claim that it will stop youth vaping. ... But we have essentially taken a big chunk out of what was once a market leader."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per the deal, Juul will now "refrain from all youth marketing, paid product placement, advertising on public transportation, funding education programs, [and] depicting anyone under 35 years old in advertisements or using cartoons in ads, among other marketing activities," Bloomberg summarizes, per a statement from Tong. The company also agreed not to advertise on billboards or use paid influencer promotions in its marketing.
Juul, meanwhile, called the settlement "a significant part of our ongoing commitment to resolve issues from the past" — though it said it was not admitting to any wrongdoing, per the Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Why is MAGA turning on Amy Coney Barrett?
Today's Big Question She may be the swing vote on Trump cases
By Joel Mathis, The Week US Published
-
Gavin Newsom's podcast debut is not going over well with some liberals
IN THE SPOTLIGHT The first episode of the California Governor and potential presidential candidate's 'This is Gavin Newsom' featured cozy conversation with far-right operative Charlie Kirk and a surprisingly conservative stance on transgender athletes
By Rafi Schwartz, The Week US Published
-
'Extremists still find plenty of digital spaces'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published